Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 9/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1553746 | 0.82 | ALDH1A1 (0.51) | SRD5A2ALDH1A1POLBRAB9ALMNA | |
| SCHEMBL8630154 | 0.82 | HPGD (0.56) | ALDH1A1HPGDRAB9ALMNAL3MBTL1 | |
| SCHEMBL2993708 | 0.78 | SRD5A2 (0.57) | SRD5A2ALDH1A1POLBRXFP1LMNA | |
| SCHEMBL1553692 | 0.76 | HPGD (0.61) | MGLLALDH1A1POLBHPGDLMNA | |
| SCHEMBL6988277 | 0.76 | ALDH1A1 (0.57) | SRD5A2ALDH1A1POLBRXFP1LMNA | |
| SCHEMBL1553898 | 0.74 | HPGD (0.38) | ALDH1A1HPGDLMNAL3MBTL1 | |
| SCHEMBL5187550 | 0.73 | ALDH1A1 (0.57) | SRD5A2ALDH1A1POLBRXFP1LMNA | |
| SCHEMBL507614 | 0.72 | KMT2A (0.66) | SRD5A2MGLLALDH1A1POLBHPGD | |
| SCHEMBL14335438 | 0.72 | SRD5A2 (0.62) | SRD5A2MGLLPOLBRAB9AMEN1 | |
| SCHEMBL26622715 | 0.72 | SRD5A2 (0.62) | SRD5A2MGLLPOLBRAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1670740-B1 | CLEAR PHOTOPOLYMERIZABLE SYSTEMS FOR THE PREPARATION OF HIGH THICKNESS COATINGS | LAMBERTI SPA (IT) | 2011-04-27 | — | — | EP | disclosed |
| US-7534880-B2 | Clear photopolymerizable systems for the preparation of high thickness coatings | LAMBERTI SPA (IT) | 2009-05-19 | — | — | US | disclosed |
| US-20060246228-A1 | Clear photopolymerizable systems for the preparation of high thickness coatings | LAMBERTI SPA (IT) | 2006-11-02 | — | — | US | disclosed |
| EP-1670740-A2 | CLEAR PHOTOPOLYMERIZABLE SYSTEMS FOR THE PREPARATION OF HIGH THICKNESS COATINGS | Lamberti Spa (IT) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005014515-A2 | CLEAR PHOTOPOLYMERIZABLE SYSTEMS FOR THE PREPARATION OF HIGH THICKNESS COATINGS | LAMBERTI SPA (IT) | 2005-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246228-A1 | Clear photopolymerizable systems for the preparation of high thickness coatings | CDH1, CLTA, VCL | SRD5A2 4185/4885MGLL 3387/4885ALDH1A1 4625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.